VPTDF - Ventripoint Issues Option Grants and Reports Exercise of Options
(TheNewswire)
Toronto, O N - TheNewswire - May 17, 2023 - VentripointDiagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT ) ( OTC:VPTDF) announces that in January 2023 the Corporation granted anaggregate of 1,115,000 options to directors, officers, employees,contractors and consultants of the Corporation with an exercise priceof $0.30 and with terms of 10 (ten) years and vesting from immediatelyto over 3 (three) years. Of these option grants, 850,000 were awardedto directors and officers of the Corporation. In May 2023, theCorporation granted an aggregate of 500,000 options to a consultant ofthe Corporation with an exercise price of $0.20 and with terms of 2(two) years and vests quarterly at 3, 6, 9 and12 months TheCorporation now has 5,463,641 options available for future grantsunder the Stock Option Plan as approved by shareholders at the lastSpecial and Annual General Meeting on August 16, 2022.
Since the last update (see NR January 21, 2022), a total of 1,005,000 options were exercised witha weighted average price of $0.30 per share for gross proceeds to theCorporation of $198,450. There are currently 10,218,750 optiongrants outstanding with exercise prices between $0.10 to $0.70 with aweighted average price of $0.28, and 6,983,333 of these options havevested.
The Corporation currently has 156,823,905 common shares issued andoutstanding.
About Ventripoint DiagnosticsLtd.
Ventripoint has become an industry leader in theapplication of AI (Artificial Intelligence) to echocardiography.Ventripoint's VMS products are powered by its proprietary KBRtechnology, which is the result of a decade of development andprovides accurate volumetric cardiac measurements equivalent to MRI.This affordable, gold-standard alternative allows cardiologistsgreater confidence in the management of their patients. Providingbetter care to patients serves as a springboard and basic standard forall of Ventripoint's products that guide our future developments. Inaddition, VMS+ is versatile and can be used with all ultrasoundsystems from any vendor supported by regulatory market approvals inthe U.S., Europe and Canada.
For further information, please contact:
Jonathan Robinson
416-669-1001
Neither the TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this news release.
Forward Looking Statements
This news release contains forward-looking statementsand forward-looking information within the meaning of applicablesecurities laws. The use of any of the words "expect","anticipate", "continue", "estimate","objective", "ongoing", "may","will", "project", "should","believe", "plans", "intends'' and similarexpressions are intended to identify forward-looking information orstatements. The forward-looking statements and information are basedon certain key expectations and assumptions made by the Corporation . Although the Corporation believes that theexpectations and assumptions on which such forward-looking statementsand information are based are reasonable, undue reliance should not beplaced on the forward-looking statements and information because the Corporation can give noassurance that they will prove to be correct.
Since forward-looking statements and informationaddress future events and conditions, by their very nature theyinvolve inherent risks and uncertainties. Actual results could differmaterially from those currently anticipated due to a number of factorsand risks. Factors which could materially affect such forward-lookinginformation are described in the risk factors in the Corporation 's most recent annualmanagement's discussion and analysis that is available on the Corporation 's profile onSEDAR at www.sedar.com. Readers arecautioned that the foregoing list of factors is not exhaustive. Theforward-looking statements included in this news release are expresslyqualified by this cautionary statement. The forward-looking statementsand information contained in this news release are made as of the datehereof and the Corporation undertakes no obligation to update publicly or revise anyforward-looking statements or information, whether as a result of newinformation, future events or otherwise, unless so required byapplicable securities laws.
Copyright (c) 2023 TheNewswire - All rights reserved.